Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects - PubMed (original) (raw)
Clinical Trial
Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects
Trevor A Mori et al. Free Radic Biol Med. 2003.
Abstract
n-3 fatty acids reduce the risk of cardiovascular disease via a number of possible mechanisms. Despite this, there has been concern that these fatty acids may increase lipid peroxidation. The data in vivo are inconclusive, due in part to limitations in the methodologies. In this regard, the measurement of F2-isoprostanes provides a reliable assessment of in vivo lipid peroxidation and oxidant stress. This study aimed to assess the effects of supplementation with purified eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA), the two major n-3 fatty acids, on urinary F2-isoprostanes and markers of inflammation, in type 2 diabetic patients. In a double-blind, placebo controlled trial of parallel design, 59 nonsmoking, treated-hypertensive, type 2 diabetic subjects, were randomized to 4 g daily of purified EPA, DHA, or olive oil for 6 weeks, while maintaining their usual diet. F2-isoprostanes, measured using gas chromatography-mass spectrometry in 24 h urines and C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha), were measured before and after intervention. Thirty-nine men and 12 women aged 61.2 +/- 1.2 years, with body mass index (BMI), 29.5 +/- 0.5 kg/m2; 24 h blood pressure, 138/73 mmHg; HbA1c, 7.3 +/- 0.1% and fasting glucose, 7.9 +/- 0.2 mmol/l completed the intervention. Baseline urinary F2-isoprostanes were positively associated with HbA1c (p=.011) and fasting glucose (p=.032). Relative to the olive oil group, postintervention urinary F2-isoprostanes were decreased 19% by EPA (p=.017) and 20% by DHA (p=.014). There were no significant changes in CRP, IL-6, and TNF-alpha following EPA or DHA supplementation. In regression analysis, Delta F2-isoprostanes were positively associated with Delta HbA1c (p=.007) independent of treatment group; and with Delta TNF-alpha (p=.034) independent of age, gender, BMI, and treatment group. There were no associations with Delta CRP or Delta IL-6. This study is the first report demonstrating that either EPA or DHA reduce in vivo oxidant stress without changing markers of inflammation, in treated hypertensive, type 2 diabetic subjects.
Similar articles
- Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.
Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Beilin LJ. Woodman RJ, et al. Am J Clin Nutr. 2002 Nov;76(5):1007-15. doi: 10.1093/ajcn/76.5.1007. Am J Clin Nutr. 2002. PMID: 12399272 Clinical Trial. - The omega-3 fatty acids EPA and DHA decrease plasma F(2)-isoprostanes: Results from two placebo-controlled interventions.
Mas E, Woodman RJ, Burke V, Puddey IB, Beilin LJ, Durand T, Mori TA. Mas E, et al. Free Radic Res. 2010 Sep;44(9):983-90. doi: 10.3109/10715762.2010.492830. Free Radic Res. 2010. PMID: 20540666 Clinical Trial. - Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans.
Mori TA, Bao DQ, Burke V, Puddey IB, Beilin LJ. Mori TA, et al. Hypertension. 1999 Aug;34(2):253-60. doi: 10.1161/01.hyp.34.2.253. Hypertension. 1999. PMID: 10454450 Clinical Trial. - Effects of EPA and DHA on blood pressure and inflammatory factors: a meta-analysis of randomized controlled trials.
Guo XF, Li KL, Li JM, Li D. Guo XF, et al. Crit Rev Food Sci Nutr. 2019;59(20):3380-3393. doi: 10.1080/10408398.2018.1492901. Epub 2019 Feb 4. Crit Rev Food Sci Nutr. 2019. PMID: 29993265 Review. - Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S, Arora RR, Singh M, Khosla S. Singh S, et al. Am J Ther. 2016 May-Jun;23(3):e905-10. doi: 10.1097/MJT.0000000000000165. Am J Ther. 2016. PMID: 25828517 Review.
Cited by
- The differential effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors: an updated systematic review of randomized controlled trials.
Choi GY, Calder PC. Choi GY, et al. Front Nutr. 2024 Sep 30;11:1423228. doi: 10.3389/fnut.2024.1423228. eCollection 2024. Front Nutr. 2024. PMID: 39403396 Free PMC article. - Obeticholic acid and ferrostatin-1 differentially ameliorate non-alcoholic steatohepatitis in AMLN diet-fed ob/ob mice.
Li S, Zhuge A, Wang K, Xia J, Wang Q, Han S, Shen J, Li L. Li S, et al. Front Pharmacol. 2022 Dec 16;13:1081553. doi: 10.3389/fphar.2022.1081553. eCollection 2022. Front Pharmacol. 2022. PMID: 36588706 Free PMC article. - A Revision on the Effectiveness of Omega-3 Polyunsaturated Fatty Acids as Monotherapy in the Treatment of Major Depressive Disorder.
Accinni T, Panfili M, Tarsitani L, Biondi M, Pasquini M, Maraone A. Accinni T, et al. Int J Clin Pract. 2022 Nov 16;2022:3801235. doi: 10.1155/2022/3801235. eCollection 2022. Int J Clin Pract. 2022. PMID: 36474548 Free PMC article. Review. - Effect of Omega-3 Fatty Acids on Telomeres-Are They the Elixir of Youth?
Ogłuszka M, Lipiński P, Starzyński RR. Ogłuszka M, et al. Nutrients. 2022 Sep 9;14(18):3723. doi: 10.3390/nu14183723. Nutrients. 2022. PMID: 36145097 Free PMC article. Review. - The effects of consuming a Mediterranean style diet on associated COVID-19 severity biomarkers in obese/overweight adults: A systematic review.
Moore E, Fadel A, Lane KE. Moore E, et al. Nutr Health. 2022 Dec;28(4):647-667. doi: 10.1177/02601060221127853. Epub 2022 Sep 21. Nutr Health. 2022. PMID: 36131504 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous